Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp. (BLAC) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001840425 · BLAC · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001840425 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) has submitted 210 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2023. As a Financial Services sector company with CIK 0001840425, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Bellevue Life Sciences Acquisition Corp.'s most comprehensive regulatory disclosure. The most recent Bellevue Life Sciences Acquisition Corp. 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical BLAC 10-K annual reports are available from 2021 through 2026.
Investors researching Bellevue Life Sciences Acquisition Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BLAC SEC Filings · 8 questionsBellevue Life Sciences Acquisition Corp. (BLAC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 210 filings and access original documents at no cost. Bellevue Life Sciences Acquisition Corp.'s CIK is 0001840425.